Patents by Inventor Maria Erlandsson

Maria Erlandsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8071785
    Abstract: Radioactively labeled derivatives of (R)-3-(1-phenylethyl)-3H-imidazole-4-carboxylic acid esters and one-step methods for preparing these compounds are provided. The radioactively labelled compounds, and pharmaceutical acceptable salts and solvates are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography (PET) for the diagnosis of adrenal cortical masses such as incidentaloma, adenoma, primary and metastatic cortical carcinoma. Associated kits and method for PET studies are also provided.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: December 6, 2011
    Assignee: GE Healthcare Limited
    Inventors: Bengt Langstrom, Farhad Karimi, Elisabeth Blom, Maria Erlandsson
  • Publication number: 20090297447
    Abstract: Radioactively labeled derivatives of (R)-3-(1-phenylethyl)-3H-imidazole-4-carboxylic acid esters and one-step methods for preparing these compounds are provided. The radioactively labelled compounds, and pharmaceutical acceptable salts and solvates are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography (PET) for the diagnosis of adrenal cortical masses such as incidentaloma, adenoma, primary and metastatic cortical carcinoma. Associated kits and method for PET studies are also provided.
    Type: Application
    Filed: June 7, 2007
    Publication date: December 3, 2009
    Inventors: Bengt Langstrom, Farhad Karimi, Elisabeth Blom, Maria Erlandsson